MuscleHormonesAnti-AgingSubcutaneous

CJC-1295 / Ipamorelin Blend

Typical Dose

100–300 mcg

Frequency

5 nights/week

Half-Life

~30 min (CJC no DAC) + ~2 hrs (Ipamorelin)

Research-use dosing; specific study population not established.

CJC-1295 / Ipamorelin Blend Overview

Mechanism of Action

Synergistic GH secretagogue blend. CJC-1295 (no DAC) stimulates GHRH receptors while Ipamorelin activates ghrelin receptors, producing robust GH release with minimal side effects.

Half-Life

~30 min (CJC no DAC) + ~2 hrs (Ipamorelin)

Timing

Before bed on empty stomach

Alternatives in this class

Same mechanism as CJC-1295 / Ipamorelin Blend — use as an alternative, not combined together.

  • Tesamorelin
  • GHRP-6
  • Sermorelin

CJC-1295 / Ipamorelin Blend Dosing Protocol

Standard

100-300 mcg combined, daily

CJC-1295 / Ipamorelin Blend Expected Timeline

No timeline data available.

CJC-1295 / Ipamorelin Blend Side Effects

Water retention

Tingling/numbness

Increased hunger

CJC-1295 / Ipamorelin Blend Research Studies

No studies referenced.

CJC-1295 / Ipamorelin Blend FAQ

Why combine CJC-1295 and Ipamorelin?

They work on different receptors for synergistic GH release with fewer side effects than either alone.

Related Protocols